Nantes, France, April 15, 2026 - 7:30am CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage ...
Proposed business combination structured to result in a new Irish public company listed on the Nasdaq Capital MarketConsideration to Blue Finance ...
Strong start of the year with Q1 2026 revenue up +13.6% in constant currencies. Revenue reaching € 51.0 million; +13.6% in constant currencies, in line with FY planned trajector ...
Under two different Illinois laws, people charged with sex offenses are subject to indefinite detention. Some people who’ve ...
The business rescue of Tongaat-Hulett Limited (THL) has arguably been just such a bloody charade, implicating both the ...
Bored Panda on MSN
53 stories about weaponized incompetence that might break your heart
Claiming “I can’t do it” can be a harmless excuse, until it’s used strategically. Some adults have mastered this tactic to ...
We’ve put together some practical python code examples that cover a bunch of different skills. Whether you’re brand new to ...
Mine clearance in the Strait of Hormuz is not a matter of post-conflict cleanup. It is a defining element of the current ...
Following a total ban on non-US made routers, the Federal Communications Commission is allowing Netgear to sell wireless ...
The standoff over the Strait of Hormuz escalated again Saturday as Iran reversed its reopening of the crucial waterway and ...
OSE Immunotherapeutics Evolves its Leadership Team Thomas Gidoin and Aurore Morello appointed Deputy CEO and CSO, respectively Nantes, France, April 14, 2026 - 6:00pm CEST - OSE Immunotherapeutics SA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results